Make the visit about your concern
Jot down the concern that sent you looking for peptide care. Describe what you notice, when it gets in the way and what you hope a useful change would look like. Use your own words. You do not need to fit the concern into a treatment menu before discussing it.
Bring a medicine list
List your current medicines alongside any supplements. Keep the questions that matter to you with that list. Bring any written offer too. Ask the clinician to connect each proposed step to the concern you described. A question about feeling tired, for example, can begin as a question rather than a request for a named product.
Ask who makes each decision
The Maryland law current November 3, 2026 requires an appropriate evaluation before online treatment or prescribing.
Ask who reviews the information you send and who decides what comes next. For each test proposed, ask what the clinician hopes to learn from it. If an in-person exam may be needed, ask how it would be arranged. Find out how to add information that did not fit into a form.
The person treating you must check where you are, whether you are in Maryland and who is with you at a live remote visit. That is required by the Maryland physician board rules checked November 3, 2026.
Choose somewhere you can talk freely and say if someone else is with you. Ask how a technical problem would be handled. Those practical points belong in the plan as much as the product discussion does.
Keep the names
Keep the clinician’s name and profession with the service’s contact details. If a pharmacy is involved, record its name separately. Ask which questions go to the clinician and which go to the pharmacist.
Talk through the hoped-for change
If a medicine is proposed, ask for the full name and intended use. Ask why it was chosen over other approaches. What change would the clinician look for? How would that change be reviewed? What would lead to a different plan? Write down the answer in words you could use to describe the proposal to someone you trust.
If compounding is proposed
For compounded drugs, FDA approval is absent as of the November 3, 2026 check. FDA does not assess these drugs before sale for benefit, quality and safety.
If that is the kind of product proposed, ask why an approved medicine does not meet the need. Also ask what evidence applies to the specific preparation and what information is missing. It is reasonable to leave a space on the page for an unanswered question.
Ask the clinician to discuss risks and other options in the same conversation as hoped-for benefits. Bring up anything that might change the plan, including another medicine, a change in health or pregnancy plans. Ask for product-specific answers rather than a rule for all peptides.
Before agreeing to a paid plan, ask for the ongoing charges, the review process and the cancellation terms. If you need time to think, keep the proposal and return to the questions that matter most to you.
Take these questions to the conversation
Mark each box once the reply makes sense to you. An empty box is a reminder to return to that point, not a score for the visit. Use the list while preparing, comparing a service or reviewing what was said afterward.